Search results for "10054"

showing 3 items of 13 documents

Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis.

2022

Abstract Objective Neurological correlates of impaired insight in non-affective psychosis remain unclear. This study aimed to review and meta-analyze the studies assessing the grey matter volumetric correlates of impaired insight in non-affective psychosis. Methods This study consisted of a systematic review of 23 studies, and a meta-analysis with SDM-PSI of the 11 studies that were whole-brain and reported maps or peaks of correlation of studies investigating the grey matter volumetric correlates of insight assessments of non-affective psychosis, PubMed and OVID datasets were independently reviewed for articles reporting neuroimaging correlates of insight in non-affective psychosis. Qualit…

PsychosisPrecuneusBrainNeuroimaging610 Medicine & healthGeneral MedicineGrey mattermedicine.diseaseMagnetic Resonance ImagingCorrelationPsychiatry and Mental healthSuperior temporal gyrusmedicine.anatomical_structurePsychotic DisordersNeuroimaging10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMeta-analysismedicineHumansGeneral Earth and Planetary SciencesGray MatterPsychologyInsulaGeneral Environmental ScienceClinical psychologyRevista de psiquiatria y salud mental
researchProduct

Degradation of phosphatidylethanol counteracts the apparent phospholipase D-mediated formation in heart and other organs.

2003

Phosphatidylalcohols, such as phosphatidylethanol (PEth), are formed from phosphatidylcholine in the presence of a primary alcohol (e.g., ethanol). This 'transphosphatidylation' reaction is used as specific phospholipase D (PLD) assay. Accumulation of PEth in tissues is recognized as a reliable measure of PLD activity, as PEth is allegedly metabolically stable. The general validity of this assumption was reinvestigated in isolated rat heart, small intestine and brain slices. The half-times of 3H-PEth degradation (labelled with 3H-myristic acid and preformed by ethanol exposure for 30 min) were about 1 h in heart and small intestine, but 17 h in brain. As the formation of PEth is superimpose…

Vasodilator AgentsIschemia610 Medicine & healthGlycerophospholipidsTritium1307 Cell BiologyRats Sprague-Dawleychemistry.chemical_compoundIschemiaPhosphatidylcholineIntestine Small1312 Molecular BiologyDiazoxidemedicinePhospholipase DAnimalsMolecular BiologyEthanolPhospholipase DMyocardiumDiazoxideBrainCell Biologymedicine.diseaseSmall intestineRatsPerfusionmedicine.anatomical_structurechemistryBiochemistry10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsIschemic preconditioningPhosphatidylethanolmedicine.drugHalf-LifeBiochimica et biophysica acta
researchProduct

Loss Aversion and Risk Aversion in Non-Clinical Negative Symptoms and Hypomania

2020

In the field of behavioral decision-making, “loss aversion” is a behavioral phenomenon in which individuals show a higher sensitivity to potential losses than to gains. Conversely, “risk averse” individuals have an enhanced sensitivity/aversion to options with uncertain consequences. Here we examine whether hypomania or negative symptoms predict the degree of these choice biases. We chose to study these two symptom dimensions because they present a common theme across many syndromes with compromised decision-making. In our exploratory study, we employed a non-clinical sample to dissociate the hypomanic from negative symptom dimension regarding choice behavior. We randomly selected a sample …

lcsh:RC435-571610 Medicine & healthLoss-aversionAffect (psychology)loss-aversion170 Ethics2738 Psychiatry and Mental Health03 medical and health sciencesddc:616.890302 clinical medicineLoss aversionlcsh:PsychiatrymedicineEnhanced sensitivity10237 Institute of Biomedical EngineeringRisk-aversionrisk-aversionnegative symptomsPsychiatryNegative symptomStudent populationRisk aversiondecision-makingBrief Research ReportHypomania030227 psychiatryPsychiatry and Mental healthHypomaniaNon clinical10054 Clinic for Psychiatry Psychotherapy and Psychosomaticsloss-aversion; risk-aversion; decision-making; negative symptoms; hypomaniahypomaniaNegative symptomsmedicine.symptomPsychology030217 neurology & neurosurgeryClinical psychologyDecision-makingFrontiers in Psychiatry
researchProduct